Pharmacokinetic and Pharmacodynamic Approaches to Optimize Antibiotic Use in Neonates

Area of Science:

• Neonatal Pharmacology
• Infectious Disease Management
• Pediatric Drug Development

Background:

• Neonates, particularly preterm infants, often receive empiric antibiotics, making them common in neonatal intensive care units.
• Optimizing neonatal antibiotic dosing faces challenges including study design barriers, physiological differences from adults/pediatrics, and lack of specific pharmacodynamic targets.
• Existing pharmacokinetic (PK) and pharmacodynamic (PD) data for neonatal antibiotic dosing is evolving.

Purpose of the Study:

• To review fundamental concepts of pharmacokinetics (PK) and pharmacodynamics (PD) in neonates.
• To describe pharmacometric strategies used in current PK/PD analyses for neonatal populations.
• To examine the progression of PK/PD data influencing the dosing of three common antibiotics in neonates.

Main Methods:

• Literature review focusing on PK/PD principles and their application in neonatal antibiotic research.
• Analysis of pharmacometric approaches employed in contemporary neonatal PK/PD studies.
• Synthesis of historical and current PK/PD data for selected neonatal antibiotics.

Main Results:

• The review covers essential PK/PD concepts relevant to neonatal drug disposition and effect.
• It details various pharmacometric techniques applied to neonatal antibiotic dosing.
• The evolution of PK/PD data for three frequently used neonatal antibiotics is presented.

Conclusions:

• Understanding neonatal physiology is crucial for effective antibiotic dosing.
• Pharmacometric strategies are vital for analyzing complex neonatal PK/PD data.
• Continued research and data evolution are necessary to refine antibiotic therapy for neonates.